• Skip to main content

Parkinson’s Treatment Report

www.ParkinsonsTreatmentReport.com

APL-130277

Study to Evaluate APL-130277 in Subjects With Parkinson’s Disease Complicated by Motor Fluctuations

September 25, 2019

https://clinicaltrials.gov/ct2/show/NCT03391882?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=05%2F01%2F2019&lupd_d=14&sort=nwst

Study to Evaluate APL-130277 in Subjects With Parkinson’s Disease Complicated by Motor Fluctuations

Study
STUDY TITLE:
A Study of an Investigational Drug to See How it Affects the People With Parkinson’s Disease Complicated by Motor Fluctuations (“OFF” Episodes) Compared to an Approved Drug Used to Treat People With Parkinson’s Disease Complicated by Motor Fluctuations (“OFF” Episodes)

DESCRIPTION:
Condition:   Motor OFF Episodes Associated With Parkinson’s Disease
Interventions:   Drug: APL-130277;   Drug: subcutaneous apomorphine
Sponsor:   Sunovion
Recruiting

CLINICALTRIALS.GOV IDENTIFIER:
NCT03391882

FIRST POSTED:
Fri, 05 Jan 2018 12:00:00 EST

LAST UPDATE POSTED:
05/15/19 07:32AM

STUDY LINK / URL:
https://clinicaltrials.gov/ct2/show/NCT03391882?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=05%2F01%2F2019&lupd_d=14&sort=nwst

Powered by Urgent Research

Copyright © 2025 Urgent Research